V. Papez

First name
V.
Last name
Papez
Voss, E. A., Shoaibi, A. ., Lai, Y. H., Blacketer, C. ., Alshammari, T. ., Makadia, R. ., … Ryan, P. B. (2023). Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study. EClinicalMedicine, 58, 101932. http://doi.org/10.1016/j.eclinm.2023.101932
. Y. Tan, Y. ., Papez, V. ., Chang, W. H., Mueller, S. H., Denaxas, S. ., & Lai, A. G. (2022). Comparing clinical trial population representativeness to real-world populations: an external validity analysis encompassing 43 895 trials and 5 685 738 individuals across 989 unique drugs and 286 conditions in England. Lancet Healthy Longev. http://doi.org/10.1016/s2666-7568(22)00186-6
Papez, V. ., Moinat, M. ., Payralbe, S. ., Asselbergs, F. W., Lumbers, R. T., Hemingway, H. ., … Denaxas, S. . (2021). Transforming and evaluating electronic health record disease phenotyping algorithms using the OMOP common data model: a case study in heart failure. JAMIA Open. http://doi.org/10.1093/jamiaopen/ooab001